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Abstract
Towards a 3D printed patient clone: Application to the effect of aortic regurgitation 
on the flow in the left ventricle
Max Lavigne
Heart disease is the leading cause of death in the world.  Amongst the many cardiovascular 
diseases, heart valve failure is a common reoccurrence.  Patient safety has risen to being a 
top priority focus for every field of medicine therefore heart simulators are implemented 
and expected to contribute immensely to the medical training of physicians, medical device 
testing and the study of cardiovascular fluid dynamics. Common methods to studying 
cardiovascular fluid dynamics have been the use of Doppler echocardiography or 2D plane 
analysis using particle image velocimetry.  The objective of this thesis is to design an 
innovated 3D printed heart simulator which is completely mobile and M.R.I. (magnetic 
resonance imaging)-compatible which can obtain results that are not possible with present 
methods.  The 3D printed heart simulator created for this dissertation was named the 
MaxTron system.  Among the many heart diseases that could be modeled with the system, 
aortic regurgitation was chosen to demonstrate one of its many capabilities.  Simulation was 
controlled through guided wires entering the 3D printed representation of the left side of a 
male patient’s heart.  Each leaflet of the aortic heart valve could be independently 
controlled to represent different severities of the disease.  Results demonstrate the accuracy 
of 4D flow readings and the versatility of the system. Vortex formation and particle 
pathlines formed by aortic regurgitation and mitral inflow interaction can be observed from 
any angle or plane during both diastolic and systolic phases.  Lifelike heart valves perform 
better for M.R.I. experiments when compared to both mechanical and bio-prosthetic heart 
valves that contain metal components which are less M.R.I.-compatible. 
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1.1.1. The Heart 
Pulsatile hemodynamic circulation is made possible due to synchronized muscle 
contractions within the organ known as the heart.  The controlled relaxation and 
contraction of four separate heart chambers in collaboration with four one-way valves 
between these chambers are beautifully orchestrated in a sequence that permits one-
directional flow.  The cardiovascular circulatory system provides a means for blood to 
circulate in order to transport nutrients to and from the body.  Blood cells that travel 
through our lungs exchange oxygen and carbon dioxide, while other cells traveling 
through intestines collect other essential nutrients.  The complete cycle is responsible for 
a healthy body and immune system.  The human heart is comprised of two halves each 
consisting of their own atrium and ventricle.  The cardiac cycle is divided into two 
separate phases, diastole which occurs during the filling phase of the ventricles, and 
systole which occurs during the ejection phase of the ventricles.  During diastole, the 
myocardial tissues that make up the ventricle walls relax allowing the volume to expand 
while refilling with blood [1] [2].  An electrical signal which is delivered through the 
sinoatrial and atrioventricular nodes at synchronized intervals activates the systolic cycle 
which is the contraction of myocardial tissues within the atrium and ventricle walls, thus 
reducing the volume and ejecting the blood flow in a specific trajectory.  This process 
involves specific vortex formations which optimize blood circulation and blood mixture 
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with the least damage brought upon the blood cells.  The direction of the flow is made 
possible by the heart valves between each chamber [1] [2]. 
 
1.1.2. Heart Valves 
 
Atrioventricular valves include heart valves separating atriums and ventricles.  The right 
side atrioventricular valve is known as the tricuspid valve because it has three leaflets 
whereas the left side atrioventricular valve is known as the mitral valve and consists of 
only two leaflets.  Semilunar valves include heart valves that separate the ventricle from 
major arteries.  The right side semilunar valve is known as the pulmonary valve and 
separates the right ventricle from the pulmonary artery.  The left side semilunar valve is 
known as the aortic valve and separates the left ventricle from the aorta [1] [2].  The 
location of the valves and their role in the cardiac cycle can be observed in figure 1.1 [3]. 
During the diastolic cycle the right ventricle will be filled from the right atrium through 
the opened tricuspid valve and the left ventricle will be filled from the left atrium through 
the opened mitral valve.  During this cycle the pulmonary and aortic valves are closed 
and the efficiency of the entire cycle relies heavily on the ability of the heart valves to 
resist backward flow.  When this phase is completed, both atrioventricular valves close 
due to the reverse pressure caused by the contracting ventricles which directs the flow 
towards the semi-lunar valves that are now opened.  The right ventricle ejects flow 
through the pulmonary valve into the pulmonary artery which directs the deoxygenated 
blood towards the lungs.  The left ventricle ejects flow through the aortic valve into the 




Figure 1.1: Adaptation of heart components and cycles.  Modified from image found 
on the “Texas Heart Institute” website [3] 
There are prosthetic replacements available on the market meant to replace diseased or 
malfunctioning heart valves.  There are many types of cardiac valve substitutes that can 
be implanted into a patient.  Although these replacement valves allow patients to continue 
living, valve life expectancies vary along with patient compatibility.  There are many 
potential side effects implicated with prosthetic heart valves to varying degrees.  A few 
examples include thrombosis (blood clotting), inefficient hemodynamic performance and 
blood cell damage [4].  The study of heart valve functionality to improve prosthetic heart 
valve designs is commonly studied through in vitro methods [5], which refers to 

























1.1.3. Intra-cardiac Pressure 
 
The opening and closing of heart valves are mostly controlled by the pressure differences 
created between chambers and arteries.  During diastole, the ventricles are relaxed which 
lowers the pressure within the ventricles allowing higher inflow pressures to open the 
tricuspid and mitral valves.  Due to their orientation, the pulmonary and aortic valves 
remain closed till the end of diastole.  When the ventricles are filled and systole begins, 
the pressure difference created by the contracting ventricles accomplishes two things.  
First, the tricuspid and mitral valves are closed.  Secondly, the pulmonary and aortic 
valves are opened [1] [2].  The complete cycle is a choreographed series of pressure 
differences and valve functionality which permits hemodynamic circulation throughout 
the body.  Pressure waveforms are of particular importance in cardiovascular research 
because they can quantifiably assist in the identification of cardiovascular disease 
severity [1].  Figure 1.2, commonly known as Wigger’s diagram, demonstrates the 
pressure waveforms created by the left side of a healthy heart.  Whenever a patient’s 
pressure waveforms deviate from their expected shape, this can be cause for further 
investigation.  Peaks of this waveform coincide with ventricle contraction, or ejection 
phase at 120 mmHg.  The peak of the smaller wave formed shortly after is known as the 
E wave.  It coincides with the rapid filling or inflow phase.  Atrial systole is known as the 




Figure 1.2: Adaptation of Wigger’s diagram.  Sections 2 and 3 represent the systolic 
peak and sections 5, 6 and 7 represent the diastolic phase.  Modified from image 
found in the “Advances in Physiology Education” journal [6] 
 
1.1.4. Heart Disease 
 
The World Health Organisation recognizes cardiovascular disease as the global number 
one cause of death that is responsible for taking an average of 18 million lives per year 
[7].  In Canada, it is estimated that cardiovascular disease is responsible for one third of 
all deaths of the Canadian population and represents 16% of all hospitalizations, not to 
mention costing the Canadian economy approximately 22$ billion dollars a year [8].  As 
the threat continues to escalate, continued efforts towards research and prevention are 
crucial to finding solutions, including developing new tools which can allow for better 
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1.1.5. Heart Valve Disease 
                                                                                                                           
Aortic and mitral valve replacement surgeries are the most commonly performed 
amongst heart valve surgeries [9] and valve replacement is the second most common 
reason for heart surgeries [4].  Proper circulation relies heavily on the functionality of 
heart valves which depends on the health of the valve’s leaflets.  Calcification is 
commonly accumulated upon the leaflets, impeding them from either opening or closing 
completely, which can eventually lead to certain cardiovascular complications [10].  
When heart valves function inefficiently, common associated pathologies are known as 
stenosis and regurgitation [4].  This dissertation shall focus on aortic regurgitation which 
occurs when blood leaks back through the valve when the valve is incapable of closing 
completely [1].  Defective valves cause circulatory dysfunction which can eventually lead 
to cardiac arrest.  To prevent this, the remedy is surgery where a heart valve can either be 
repaired or replaced.  Some medical procedure methods are proven to work better than 
others and can be better suited for a specific patient therefore careful planning and 
preventative measures must be taken [1].  All four heart valves are prone to such diseases 
and represent a very challenging surgery to perform [4].  
 
1.1.6. Aortic Regurgitation 
 
Aortic regurgitation is a cardiovascular defect wherein the aortic valve does not close 
completely during diastole and allows a regurgitating jet to flow backward into the left 
ventricle.  Studies estimated that 13% of men and 8.5% of women from a sample 
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population group were suffering from different severities of aortic regurgitation [11].  
Aortic regurgitation worsens over time and can lead to multiple potential side effects.  
Studies have proven that the regurgitating jet from the aorta does interfere with mitral 
inflow causing flow disturbances [12].  Stagnant blood that spends more time in the 
ventricle than expected can lead to thrombi, which is the coagulation of blood [13].  
Figure 1.3 demonstrates how the left ventricle is filled from two sources in patients with 
chronic aortic regurgitation. 
 
Figure 1.3: Adaptation of chronic aortic regurgitation.  Modified from image found 
in the book entitled “Cardiovascular Physiology Concepts” [14] 
Chronic aortic regurgitation occurs when the left ventricle increases in size to compensate 
for the excess inflow from both the mitral and aortic valve [14].  The increased volume is 
expected to circulate at the same speed as under normal conditions which leads to 
hypertrophy of the left ventricle.  Hypertrophy results from the extra work that the 
muscles of the heart endure due to the additional volume ejection performed at the same 









mass which tends to prohibit efficient functionality of the heart [15].  Acute aortic 
regurgitation differs from the fact that the left ventricle does not compensate in a volume 
change which in turn results in an increased diastolic pressure and decreased systolic 
pressure due to increased backward flow [16]. 
 
1.2.1. Cardiovascular Research 
 
Latest advancements in technology need to be continually integrated into cardiovascular 
fields of research to further benefit progress.  The importance of reliable cardiovascular 
medical training and device testing is growing proportionally to this trending epidemic.  
The most common tool used for most testing and training is heart simulators which 
provide a neutral testing environment.  The anatomically correctness of simulators is 
constantly evolving with an abundance of options becoming available.  3D bio-printing 
options can now allow the opportunity of producing engineered tissue with increasing 
complexity which can be applied towards the creation of vascularized constructs, 
myocardium and heart valve conduits with a precision range of 50-300 𝜇m [17]. 
 
1.2.2. Cardiovascular Device Testing 
 
There is extensive research performed on studying the flow across prosthetic heart valves 
during operation where the ultimate goal is to minimize blood cell damage, coagulation 
potential and optimize vortex formation.  Coagulation is a common build up on prosthetic 
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heart valve leaflets that form over time and limit the functionality of the mechanical heart 
valve [1].  Studying these effects can represent a challenge due to the complex geometry 
of cardiovascular anatomies and flow patterns involved in the cardiovascular circulatory 
system.  The choice of a replacement valve is usually specific to a patient after 
considering the levels of risk involved, estimated lifespan of the procedure and 
compatibility of the patient towards anticoagulant medication.  Mechanical heart valves 
made of metal components and bio-prosthetic tissue valves made from either explanted 
porcine valves or pericardium material [18] are the most commonly offered to patients 
each with their advantages and disadvantages [19].  Mechanical valves tend to have better 
resistance to clots, however require a lifelong anticoagulation therapy.  Tissue valves 
behave more like natural heart valves and respect the proper vortex formations formed.  
However, tissue valves have a shorter lifespan than their mechanical counterparts and 
therefore are rarely used for children [1] [19]. 
 
Figure 1.4: Adaptation of both a tissue heart valve and mechanical heart valve.  
Modified from image found on “the Drs Wolfson” website [20] 
Invasive surgeries along with non-invasive surgeries represent a risk to the patient.  Since 
there are many risks involved with heart valve surgeries many efforts are done towards 
properly matching patients and procedures in order to avoid multiple surgeries performed 
Tissue Valve Mechanical Valve
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during a patient’s lifespan.  One good example that demonstrates the importance of pre-
installation testing is the history of mechanical heart valves.  The Bjork-Shirley 
mechanical heart valve was approved for public implantation in the early 80’s and 
quickly needed to be recalled due to outlet strut fractures.  These failures would send the 
strut of the mechanical heart valve into the circulatory system leading to fatal 
consequences.  This resulted in a mortality rate of 75% of patients involved and the 
Bjork-Shirley valves removed from the market in 1986 [1]. 
In the U.S.A., the F.D.A. (Food & Drug Administration) regulates the approval of 
medical devices for use by the general public.  For prosthetic heart valves, 
insurmountable proof is required that each device is safe.  This is accomplished through 
extensive clinical trials along with a record of every valve treatment performed in 
America which is logged into a registry [21].  The need for viable ways to speed up the 
process when approving new devices is a priority mainly for the reason that people’s 
lives are on the line and time is an important factor.  At present, preliminary steps before 
clinical trials is performed using bench testing and animal testing which leaves a gap in 
between that could be filled with an adequate intermediary step within the medical device 
testing process [21].  When testing an implanted prosthetic valve, one of the most 
important performance measurements is pressure gradients which helps determine the 
success of the operation [22].  With regards to medical device testing there is still much 
room for improvements.  Interactions of heart valves with patient specific anatomies can 
now be analyzed with heart simulators before the heart valves are introduced into 
patients. This will lead to medical devices being designed for patient specific 
compatibility along with a tested delivery method.   
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1.2.3. Cardiovascular Medical Training 
 
Although medical training is only touched briefly in this dissertation leaving more 
emphasis on medical device testing, medical training is still an important option to have 
on a heart simulator that can perform multiple tasks.  The current method for medical 
training is known as the apprenticeship model which was first introduced in the early 
1900’s.  This method relies on residents shadowing doctors in practice for extended 
periods of time to learn and perform procedures through imitation and repetition under an 
expert physician’s surveillance [23].  Medical procedures vary greatly throughout the 
world and the use of the apprenticeship model creates a platform where non-uniformity in 
medical training becomes very present.  After extensive observations of this phenomenon 
the need for standardization was determined to be important.  To answer this need 
simulation based education has grown in popularity because it can provide an 
intermediary step between theory and practicing on a patient.  This approach is 
optimizing the educational procedure through improvements of technology with the 
potential of uniformity in trainings [23].  Simulators provide the opportunity to perform 
procedures in a repetitive fashion eliminating stress associated with first time interactions 
with real life patients.  Medical simulators of today also create the availability to study 
pathologies that until now have been difficult or impossible to study.  Cardiac surgery 
professors recognize that simulation training has increased the confidence and technical 
expertise of their training physicians [24].  The success of simulation-based education is 
due to the hands on experiences provided by these advancements in technology that 
improve learning.  Easily obtainable medical simulators along with consistent training 
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methods would increase the ability to implement a standardized medical training 
curriculum.  One example of quantifiable proof that improvements are brought through 
simulation based medical training is a study that introduced 3D printed heart models into 
their simulation.  Improvements of pediatric resident training results due to the addition 
of simulation-based trainings showed an increase of 51.7% in knowledge acquisition, 
61.4% in knowledge reporting and 73.1% in structural conceptualization and all of this 
done in a critical care situation [25]. 
The MaxTron system is capable of patient specific medical training which is destined to 
increase patient safety.  Simulators like these could help assess if a device and 
introduction method are valid for a specific patient [26].  These heart simulators could 
also serve the purpose of educating patients and their family members about operational 
procedures that can sometimes require parental or guardian consent. 
 
1.2.4. Cardiovascular Fluid Dynamics 
 
Cardiovascular fluid dynamic analysis can lead to the creation of mathematical models 
that help to quantify cardiovascular conditions.  Advancements in 3D imaging techniques 
now permit the creation of patient specific computer generated models.  The process 
makes use of a combination of M.R.I. readings, computed tomography and ultrasound 
contributions towards deriving equations that describe hemodynamic behaviour [27].  
These patient specific models can be used to determine important flow parameters.  
Vortex formation time and viscous energy dissipation are examples of important areas of 
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interest when investigating cardiovascular fluid dynamics.  These studies advance clinical 
diagnostic efficiency due to earlier and better evaluations of pathology severity [28].  
Present vortex formation studies are limited to 2D analysis.  Energy dissipation and other 
phenomena can be better analyzed with 4D flow data provided by a heart simulator that is 
M.R.I. compatible [29]. 
 
1.3.1. Thesis Objective 
 
Towards quantifying hemodynamic behaviour during cardiovascular circulation in 3D, an 
innovative approach was taken to develop an M.R.I.-compatible heart simulator named 
the MaxTron system.  Primarily, the M.R.I. compatibility of the fully-coupled (aortic and 
mitral valves) F.S.I. fluid-structure interaction system will be investigated along with 
steps and measures that were taken in order to optimize noise reduction during M.R.I. 
acquisitions.  Iterations needed to adapt the heart simulator and activation system to the 
M.R.I. testing platform will be discussed in the appendix section along with the many 
configurations of different 3D printed heart components, heart valves and assembly 
methods used towards optimization of the experiment process.  Benefiting from the 
M.R.I. compatibility of the system, severity progression of aortic regurgitation was 
monitored in a 3D perspective with respect to time.  Intersection vortex formation 
between different severities of aorta regurgitation and varied mitral valve orientation 
combinations were visualized using Ensight software (Siemens; Munich, Germany).  
Both improvements on the availability and user-friendliness of the simulator are directly 
aimed at impacting patient safety in a positive way.  User-friendly guidelines can be 
14 
 
followed to manufacture, assemble and operate this heart simulator at a low cost.  With 
every practicing physician having the availability to procure their own anatomically 
correct heart simulator, patient safety can be optimized to its fullest potential.  
Availability of heart simulators also benefits the field of medical device testing by 
facilitating the certification process which helps deliver these devices to the general 
public at a quicker rate.  Through the process of this present research the following 
important questions were answered.   
1) Can a heart simulator and its components be made compatible for M.R.I. 
experimentation using mostly 3D printed materials and 3D printing 
manufacturing processes? 
2) Can these heart components assemble together in an interchangeable system 
capable of representing multiple severities of a specific pathology? 
3) Can the replacement of a mitral valve be orientated in such a way as to diminish 












Chapter 2  
2 Literature Review 
2.1.1. Cardiovascular In vivo Studies 
 
The birth of cardiovascular research dates back to the renaissance.  Leonardo da Vinci 
made observations of the tricuspid valve and sinuses of Valsalva that were both a 
scientific and artistic homage of admiration to the beautiful clockworks of life [30].  This 
chapter of this dissertation shall focus mostly on cardiovascular research development 
throughout history while paying special attention to experimentation regarding 
observations of left ventricular flow and aortic regurgitation.  Early studies dating back to 
the 1970’s were mainly performed on animals like dogs and sheep using cine-
angiography which resembles motion picture x-rays.  The observations of pressure 
readings and velocity profiles led to the discovery of stable flow in the left ventricle 
which was previously believed to be turbulent [31].  Further studies revealed that there is 
great importance in the ring like vortex formation developed from the mitral valve leaflet 
tips.  This vortex formation permits proper mixing of the circulating blood, evenly 
distributes pressure along ventricle walls and optimizes flow circulation [31].  All of 
these early studies would slowly evolve proportionally with the contributions that 
advancements in technology would start to offer.  When echocardiography was 
introduced in the early 1980’s blood circulation could be better analysed and specific 
characteristics could be determined in a non-invasive manner.  The 2D Doppler 
ultrasound method provided means towards obtaining direction, velocity and turbulence 
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from observed blood flow.  This method proved efficient especially for the study of aortic 
regurgitation because visualization of the regurgitant jet was made possible in real time 
[32].  Using 2-dimensional Doppler flow imaging in a similar study that was aimed at 
grading the severity of mitral regurgitation, researchers noticed different orientations and 
dynamics of the regurgitant jet which had not been noticed before the use of this method.  
The correlation between Doppler imaging and angiography were validated with regards 
to evaluating the severity of mitral regurgitation [33].  Distinguishable flow patterns of 
specific pathologies were now quantifiable and would lead to better diagnostics.  
Ultrasound-based techniques offer great potential for capturing measurements by means 
that have fewer constraints than M.R.I. methods which are restricted by non-
ferromagnetic materials, expensive costs and longer post processing times [34].  Despite 
these facts, M.R.I. readings have proven to be superior than other methods with regards 
to acquisitions of velocity profiles and flow trajectories in 3-dimensions with respect to 
time [35] [36].  A method called particle tracing that is used to visualize flow in fluid 
dynamics was applied to assist researchers using M.R.I. velocity mapping due to their 
readings being scattered with noise [37].  Another innovative technique using echo 
sequencing proved to be an effective way to obtain better readings related to flow 
velocity.  This discovery would solve many issues which were related to loss of signal 
resulting from rapid blood flow [38].  The method is combined with phase contrast 
cardiovascular magnetic resonance imaging and measurements obtained with this method 
of blood flow velocities, vector fields, pathlines, streamlines and volumetric 
quantifications helped the understanding of pathological blood flow dynamics [39].  
Another great contribution for cardiovascular research was in 1994 when visualisation of 
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blood flow using M.R.I. velocity mapping techniques in patients alongside a flow 
phantom validated further in vitro studies using this approach.  The study was however 
limited to a single 2D plane of analysis [40].  These early in vivo experiments had many 
limitations which mostly involved using living patients.  Humans are not meant to spend 
long hours in an M.R.I. scanner like those needed for cardiovascular research and the 
availability of willing patients with increasing severities of a similar pathology is scarce.  
The obvious advantage of in vitro experimentation is the fact that the process does not 
involve actual patients and can be performed repetitively with fewer limitations.  Further 
advancements involved using Navier-Stokes equations for incompressible flow to 
represent pressure fields which were later validated through in vivo M.R.I. acquisitions 
and in vitro phantoms.  This method provided the potential of discovering relationships 
between pressure and blood flow within normal and pathology affected cardiovascular 
systems [36]. 
 
2.1.2. Cardiovascular In vitro Studies 
 
With the aim of patient safety and bettering research capabilities, in vitro experimentation 
started gaining much deserved popularity.  Early studies that were performed using mock 
setups instead of actual patients were aimed at better understanding heart valve 
functionality and potential risks involved.  There are mainly three types of systems used 
for the testing of prosthetic heart valves in cardiovascular in vitro research which are 
pulsatile flow (pulse duplicator) systems, steady flow systems or accelerated flow 
systems which are used for testing the life span of a medical device [41].  Studying the 
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way a heart valve closes was first performed using a piece of see-through tubing and 
produced wonderful insight to the fluid dynamics involved [42].  Model left ventricles 
were constructed in 1972 using a transparent rubber bag submerged in a tank of water.  
The bag would have both a model mitral valve and aortic valve constructed from nylon 
netting and silicone rubber in order to direct flow.  Circulation of the modeled left 
ventricle was generated by a piston pump applying and relieving pressure to the filled 
tank [43], which is an approach still commonly used today.  The following figure 
demonstrates the setup used for that experiment. 
 
Figure 2.1: Adaptation of the Bellhouse experiment model of left ventricular flow.  
Modified from image found in an article from the “Cardiovascular Research” 
journal [43] 
Other studies would focus on closer observations of valve functionality.  Innovative 
prosthetic heart valves were studied to prove their superiority over previous models.  Ball 
valves or disc elements were commonly used as prosthetic heart valves but represented 










anatomical mitral valve functions were proven to develop the vortex formation required 
for optimal cardiovascular circulation [44].  Numerous prosthetic valves were analysed 
with regards to regurgitation using a pulse duplicator.  Regurgitation is a common 
occurrence when dealing with any replacement heart valve that at the present do not close 
completely as naturally intended.  Regurgitation was found to increase proportionally 
with regards to heart rate and as a result cardiac output was inversely affected [45].  
Another study compared the St. Jude bileaflet mechanical valve, Bjork-Shiley tilting disc 
and Carpentier-Edwards porcine valves.  It was found that despite the St. Jude valve 
having the most regurgitation amongst the valves, it demonstrated the best fluid dynamic 
performance [46].  Comparison of older and newer designs of commonly used prosthetic 
heart valves would show differences in peak velocities obtained by each valve during 
functionality and the results showed that peak jet velocities and turbulence levels were 
improved by the newer designs.  These in vitro studies were intended to assist in the 
selection for patient/valve compatibility and improvements made towards prosthetic 
valve designs [47].   
Color Doppler imaging was optimized through in vitro experiments.  The use of a left 
heart pulse duplicator was chosen for a study for the controllability of the system and the 
possibility of observing regurgitant jets coming from the aortic passage.  Laser Doppler 
velocimetry imaging provides two dimensional readings as opposed to the one dimension 
obtained from pulsed Doppler flow mapping.  This non-invasive method of determining 
severities of aortic regurgitation was preferable over contrast angiography that requires 
invasive catheterization.  Aortic regurgitation was graded in that experiment by 
maximum length and width of the jet along with color variance due to turbulence [48].    
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2.1.3. Cardiovascular Research of Today 
 
Recent contributions of computer simulations have been helping develop sophisticated 
tools useful for cardiovascular research.  Extensive 3-dimensional studies of mitral valve 
orientation were done using a computational approach. The computed inflow showed 
variations depending on the orientation which was validated visually with the in vitro 
setup but quantitative validation required 3-dimensional in vitro data not available during 
the time of the study [49].  Thromboembolism is still a major disadvantage of prosthetic 
heart valves and studies are continuously being done to provide improvements.  
Cardiovascular simulators and 2D software simulations play an important role in this 
field of research.  The main objective of these studies is to minimize stagnation zones and 
regions of elevated stress associated with these medical devices to a level that eliminates 
the need for anticoagulation medicine commonly prescribed with heart valve 
replacements [50].   
The evolution of M.R.I. acquisitions has also continued to prosper.  M.R.I. data was first 
obtained using 1.5T (Tesla) machines but slowly transitioned to 3T machines due to 
improved data readings.  First the head and then the body were scanned with 3T M.R.I. 
Scanner but cardiovascular magnetic resonance was slower towards the transition.  The 
continuous fluctuations of the heart and the closeness of the heart to the lungs led to low 
signal to noise acquisitions.  The increase in magnetic magnitude was eventually 
beneficial and increased the signal to noise ratio which allowed easier readings of the 
results [51].  Numerical methods along with in vivo M.R.I. data were used in combination 
in order to predict patient specific intra-ventricular flow.  ANSYS Fluent (ANSYS; 
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Canonsburg, PA, U.S.A.) software was used to simulate 2D intra-ventricular flow which 
was validated with in vitro and M.R.I. in vivo data.  The asymmetric shape of the mitral 
valve was shown to direct the mitral inflow jet towards the posterior wall [52].   
Recent studies that were performed in vivo with open-chest dogs were focused on 
observing energy loss from aortic regurgitation.  They came to the conclusion that using 
vector flow mapping was an efficient method to determine the severity of aortic 
regurgitation because diastolic energy loss would noticeably increase proportionally to 
the diseases severity [53].  L.C.F.D. colleague Dr. Giuseppe Di Labbio studied 
progressive chronic aortic regurgitation by recreating different severities of the heart 
disease with the use of an in vitro system created by him and fellow Capstone team 
members.  The data obtained revealed a reversal of the vortex created in the left ventricle 
due to severe aortic regurgitation along with an increase in viscous energy dissipation 
[28].  Continuation of Di Labbio’s studies showed that all severities of aortic 
regurgitation seem to create turbulence within the left ventricle and also affect the central 
vortex formation which is supposed to optimize circulation and blood mixture.  The 
results of these studies were obtained using P.I.V. measurements in 2-dimensions [28].  
These results coincide with another study obtaining similar results, namely that the 
incoming regurgitant jet prohibited the mitral inflow from creating proper vortex 
formations and increased energy dissipation within the ventricle proportional to the 





2.2.1. Cardiovascular Simulators 
 
There are four main categories of simulators at the moment that are used for medical 
training, medical device testing, and cardiovascular fluid dynamic analysis.  Firstly, 
computer-based learning is a method that makes use of computers for educational 
training and simulations.  Secondly, phantoms are devices that model specific anatomies 
of interest and can be customized for training of specific skills or research.  Thirdly, 
computer-assisted mannequins which are full body simulators with a computer interface 
and combined offer the ability to simulate specific scenarios like critical care situations.  
One of the most recent additions is virtual-reality simulators which create an immersive 
experience which can be combined with haptic feedback [23].  This list shall continue to 
grow as advancements in technology persist.  A commonly used heart simulator 
throughout the world that performs similar experiments as this presentation is the 
ViVitro’s pulse duplicator (Starfish Medical; Victoria, Canada).  Their pulse duplicator 
has gained popularity for its well-known capability of reproducing several cardiac 
pathologies.  The system has setting controls that can alter the peripheral resistance, as 
well as the compliance of the system which can help study different extents of a certain 
disease.  Pressure readings can be obtained from both the aortic and mitral valves.  The 
flow is powered by a pump in a pulsatile fashion which is adjustable in order to mimic 
certain conditions of flow interactions with the prosthetic valves.  Blood circulation can 
be measured with their ViVitro data acquisition system and can be used to analyze the 
performance of each cardiac device [54].  A more recent development by ViVitro 
laboratories entitled the ViVitro Endovascular simulator can simulate any possible 
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section of the cardiovascular system due to its user-friendly reconfigurations.  This model 
is very useful for training a multitude of transcatheter or surgical vascular interventions 
as well as medical device testing [55]. 
 
Figure 2.2: ViVitro Labs Endovascular Simulator [55] 
The above figure demonstrates the bulkiness of the Vivitro Endovascular simulator that 
contains metal components which prohibit the system from being used in an M.R.I. 
scanner.  The system also does not include heart cavities and fails to represent patient 
specific anatomically correct heart components.   
 
2.2.2. 3D Printing-based Heart Simulator 
 
The L.C.F.D. laboratory is supervised by Dr. Lyes Kadem who has led many consecutive 
undergraduate teams and graduate students through cardiovascular fluid dynamic 
research innovations and continues to breach the forefront of this field’s advancements.  
The heart simulator built for this dissertation aims to answer the growing need for 
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anatomically correct heart simulators that can represent any pathology when simulating 
patient specific anatomies for medical device testing along with non-invasive delivery 
methods.  MaxTron builds off the ideas used in previous iterations built in the L.C.F.D. 
laboratories with the objective of advancing M.R.I. compatibility, increased portability, 
interchangeability, user-friendliness, availability and aesthetic appeal of the system all 
while reducing costs and need of technical skills to operate.  This is achievable by finding 
methods of manufacturing that reduce the cost and if possible create a heart simulator that 
can be used for multiple tasks/experiments which reduces the need to buy multiple types 
of systems.  One of the main approaches for most of the objectives was to take advantage 
of the advancements in 3D printing which helped with user-friendliness, availability and 
reduction of cost.  An added advantage is the increase in lifespan of the 3D printed heart 
components when compared to their silicone counterparts.  An example is the artificial 
heart made by Functional Materials Laboratory at the Swiss Federal Institution of 
Technology in Zurich, which was made using a lost-wax casting method to make a 3D 
printed silicone heart named the Soft Total Artificial Heart (sTAH).  The inconvenience 
of their remarkable innovation is the lifespan of the heart which is measured to be an 
average of 3000 beats which represents about 30 to 40 minutes of functional running time 
[56].  L.C.F.D. 3D printed heart components were printed with 0.1 mm layers within a 
potential layer resolution range of 0.05 - 0.4 mm.  3D printed heart components created 
for this project demonstrated endless usability and lasted the entirety of the project 
duration.  M.R.I. compatibility for an in vitro setup offers a chance to achieve 3D 
acquisitions of pathological hemodynamic interactions that have until now been 





3.1.1. State of the Art 
 
Cardiovascular research has evolved gradually with the help of advancements in 
technology.  Many restrictions and design iterations were required to make a 
cardiovascular simulation system that could be introduced into an M.R.I. scanner.  These 
efforts are done to advance cardiovascular fluid dynamic research with the hope of 
finding numerous solutions towards prevention, diagnostics and patient care.  Well-
designed experiment setup’s that can be performed at a rapid pace are truly beneficial for 
M.R.I. experimentation which can be cost heavy.  The following will explain the 
methodology behind creating an in vitro model capable of representing the complete 
anatomical heart and functional cardiovascular system along with preparations, 
procedures and acquisition details when using the system in an M.R.I. scanner. 
 
3.1.2. The MaxTron System  
 
In order to achieve representation of the complete heart, the system is devised into two 
separate systems to have complete control over pressure levels in each subsystem of the 
model heart.  The current design needed the reservoir of water for the left side of the 
system to be placed at a higher altitude than the right side reservoir in order to mimic 
physiological conditions.  Many left ventricle in vitro experiments rely on the pressure 
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changes of a tank of fluid to activate ventricle compressions much like the apparatus used 
in early works of Bellhouse [43] up to more recent studies performed by Di Labbio [28].  
The MaxTron model makes use of a hydraulic system that activates ventricle 
compression by physically squeezing the ventricle between a pusher and a customizable 
support structure.  Pressures in a healthy left ventricle and aorta can attain amplitudes of 
120 mmHg [6] and the right ventricle can attain peak pressures closer to 25 mmHg [57]. 
Figure 3.1 illustrates the overall setup which mainly consists of reservoirs linked to 3D 
printed heart components housed inside a fiberglass mannequin torso and activated by a 
hydraulic system involving many components.  Similarly, both separate circulatory 
systems begin by their respective reservoirs emptying into 40 Shore A hardness tubes 
which lead to valves that help control pressure, flow rate and mimic capillary resistance.  
Fluid in these experiments was regular water and not a water-glycerol solution due to the 
numerous iterations taking place during the entirety of the project which would have 
required extensive cleaning.  Upon activation of the left ventricle, the wall is compressed 
pushing fluid through the aortic valve and this segment of the cardiac cycle is known as 
the systolic cycle.  The fluid then makes its way down the aorta through the base of the 
mannequin and the flow is eventually recycled back into the reservoir completing the left 
loop of the cardiovascular circulatory system.  When the left ventricle is decompressed, 
this reduces the pressure in the chamber allowing the aortic valve to close and for the 
mitral valve to open refilling the left ventricle known as the diastolic cycle.  The right 
side functions the same way as the left side of the system, but at a lower pressure of 




Figure 3.1: Schematic overview of the left side of the Maxtron system 
 
Figure 3.2: The Maxtron System 
Figures used in this dissertation were mostly created with the help of Inkscape (Free 


























3.1.2. Simulator Casing Considerations 
 
Many parameters needed to be considered for the casing of the heart components and 
other functional items which are essentially the bulk of the system.  Since the apparatus is 
intended for M.R.I. compatibility the system needed to be mobile and compact.  The use 
of a male mannequin torso was chosen to house the system because it had the right 
dimensions, added to the realism of the simulation and could retain any water leakage 
that could occur during operation.  Any water leakage even minimal could have 
devastating consequences on the expensive M.R.I. equipment.  The inside of the 
mannequin torso was lined with a custom designed rail track system that enables 
interchangeability of the support structures that hold the heart components, hydraulic 
activation systems, and multiple tubing connections.  The choice of material for the rail 
track system was P.L.A. 3D printing filament.  P.L.A. filament has very close properties 
compared to A.B.S. filament but was chosen mainly to respect laboratory regulations 
with respect to emissions given off during 3D printing.  The 3D printer used was a 
Lulzbot Taz 6 (Aleph Objects; Loveland, CO, U.S.A.) capable of printing both solid and 
flexible 3D prints.  The following P.L.A. mechanical properties from the Ultimaker 
(Ultimaker; Utrecht, Netherlands) P.L.A. filament used were obtained using the ISO 527 




Table 1: Ultimaker P.L.A. 3D Filament Mechanical Properties [58] 
 
 
3D Printed Sample 
Infill 100% 
Tensile strength at yield (MPa) 49.5  
Tensile stress at break (MPa) 45.6 
Hardness (Shore D) 83 
Elongation at break (%) 5.2% 
Tensile modulus (MPa) 2346.5  
 
The cross section of the rail track system was designed to withstand the forces present 
during operation which include shear, torsional and tensile considerations all while 








3.1.3. Heart Components 
 
In total the system consists of six heart components, three for the left side of the heart and 
three for the right side of the heart.  The left side heart components are commonly known 
as the left atrium, left ventricle and the aorta and the fluid circulation passes through the 
components in that order in a one-directional circulation.  The right side heart 
components are commonly known as the right atrium, right ventricle and the pulmonary 
artery and the one-directional circulation passes through the components in that order.  
Usually heart components in the L.C.F.D. are made from applying layers of silicone upon 
a 3D printed model of the desired heart component.  3D Models of the heart components 
originated from C.T. and M.R.I. scans (Solid Heart Gen 2, Zygote; American Fork, UT, 
U.S.A.).  After many coats the flexible silicone can be removed from the model and be 
used for in vitro experimentation.  These silicone heart components have the advantage of 
being created with complete control over flexible compliance and transparency.  Silicone 
heart components were successfully implemented into the system but focus of this 
dissertation was maintained around the more durable, user friendly methods and 
accessibility of 3D printed heart components.  Tests were done to see the best way to 
print the heart components using NinjaTek 3D printing flexible filament named Ninjaflex 






Table 2: Ninjaflex Filament Mechanical Properties [59] 
 
 
3D Printed Sample 
Infill 100% 
Tensile strength at yield (MPa) 4  
Tensile stress at break (MPa) 26 
Hardness (Shore D) 85 
Elongation at break (%) 660% 
Tensile modulus (MPa) 12  
 
The heart components were printed as thin as possible for elasticity purposes with wall 
thicknesses of 1 to 1.2 mm.  The 3D modeling of the heart components were performed 
on Solidworks (Dassault systemes; Velizy-Villacoublay, France) which is a three 
dimensional modeling software.  Once a 3D model is made on Solidworks, the file can be 
saved as an S.T.L. file and introduced into the CURA (Ultimaker; Utrecht, Netherlands) 
slicing program compatible with the 3D printer being used.  Within the slicer interface 
many parameters can be chosen to optimize the success and material properties of the 
component.  The left atrium that has four small connections and one large connection 
represents the most complex heart component to 3D print.  One optimal way to 
successfully print the left atrium component is to position it at an elevated angle which 
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minimizes the gravity induced complications of the print.  Once completed and 
assembled, tests proved that thicker components could retain impermeability however 
thinner components of 1 mm or 1.2 mm thickness were not impermeable and droplets of 
water from the circulation would bleed through the material.  A solution brought forth by 
Dr. Lyes Kadem of using a secondary product to line the heart components with a water-
proofing membrane was implemented.  The only restriction was that the medium needed 
to be easily accessible to the general public.  Many water-proofing products and 
techniques were tried but the most efficient and easily accessible product that required 
minimal skill to apply was a temporary roof repairing product named Leakseal (Rust-
Oleum; Vernon Hills, IL, U.S.A.).  After applying an average of 5 coats on the outside of 
each component, the components were able to retain the pressures needed without any 
leakage and later proved to be robust enough to endure the friction and pushing motions 
applied by the hydraulic activation system for the entirety of the experimentation.  
Another benefit from using Leakseal was the fact that pieces could be easily sprayed after 
getting cut up and sewn back together which facilitated the many iterations performed.  
The maximal pressure limit attainable by the sprayed 3D printed heart components was 
not tested but was found to be more than adequate enough for the pressures they were 
subjected to during operations.  Luer tapered connectors were placed on the four areas of 
interest that would provide access to obtaining pressure readings from the aorta, left 
ventricle, pulmonary artery and right ventricle. 
Echocardiography readings were attempted on the system but regrettably the filament 
used for the 3D printed heart component was not compatible.  This avenue was not 





In order to connect the heart components to each other and the tubing that would 
complete the circulation, customized clamping devices were designed and created which 
were named Screwclamps because the clamping is achieved by screwing two pieces 
together.  To differentiate the Screwclamp pieces they were simply named female and 
male Screwclamp components.  The Screwclamps were made from 3D printing for 
M.R.I. compatibility.  The first limiting parameter was space therefore the Screwclamps 
were designed as small as possible all while resisting the forces they were subjected to.  
The weakest portion of the ensemble was found to be on the female Screwclamp 
component, namely the thickness of the outer wall was of particular importance.  
Iterations revealed that the minimal thickness that could be used for the female 
Screwclamp components was approximately 2 mm which was tested and proved through 
trial and error.  The threading of the Screwclamps was created to endure a clamping force 
that would secure the pieces together but would fail if tightened too hard in a manner that 
did not harm the Screwclamp or the heart components.  The Screwclamps are also used to 
secure the heart components to the heart support structure, described below, in a fashion 
that limits movement and increases predictability of the pressure waveform acquisitions.  
The heart support structure is conveniently shaped so that the Screwclamps line up in 
their respective places and can be secured in place with tie-wraps which are easy to 




3.1.5. Heart Valves 
 
There are four heart valves used in the system that direct fluid circulation in a single 
direction.  The reason the heart components are separated into six components is to 
enable access to where the heart valves are located for interchangeability purposes.  
Between the atrium and ventricles, mechanical, Lifelike (Lifelike Bio Tissue, ON, 
Canada) and three leaflet bio-prosthetic valves were tested.  Between the left ventricle 
and the aorta on the left side of the heart, different sizes of prosthetic tissue valves were 
tested which is the same valve used on the right side between the right ventricle and the 
pulmonary artery.  The bio-prosthetic heart valves that were used were the Biocor 
(Edwards Lifesciences; Irvine, CA, U.S.A.) 25, 27 and 31 mm prosthetic heart valves.  
 
 
Figure 3.3:  Representations of the heart valves used during project iterations.  
Images were found at the “Heart Valve Surgery” and “Lifelike Bio-tissue” websites 
[60] [61] [62] 
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Figure 3.4: Assembly of valve placement between the left ventricle and the left 
atrium clamped together using a custom made Screwclamp 
 
3.1.6. Heart Support Structure 
 
The current heart support structure was designed and configured for this set-up 
containing these specific heart components prepared for aortic regurgitation 
representation.  The set-up included patient specific heart components that represent 
those of a healthy heart but if any changes were brought to either of the components, 
configuration, hydraulic activation system or pathology represented, the heart support 
structure could easily be customized with 3D modeling software and 3D printed within 
an adequate time lapse.  The heart support structure is printed using P.L.A. 3D printing 
filament and is secured into place with attachments that are secured to the rail track 











Figure 3.5: Heart Support Structure 
  
3.1.7. Hydraulic Activation System 
 
The hydraulic activation system is mainly driven by an electromagnetic linear motor 
(LinMot P 01-37 x 120, NTI AG; Spreitenbach, Switzerland)  that creates a back and 
forth motion that can be set to represent different bpm’s with an adjustable stroke length.  
Stroke length used was 60 mm which facilitated experimentation at 70 bpm.  According 
to the specifications, the linear motor can deliver up to 120 N of axial force.  The servo 
drive for the motor (Servo Drive E1100-RS, NTI AG; Spreitenbach, Switzerland) helps 
regulate bpm and stroke length through the Linmot Talk 6.8.interface.  The same 
interface was used to make an amplitude waveform of 32-bit positional resolution to 
power the linear motor in a fashion that represented the functionality of a normal heart.  
The linear motor following the given waveform is attached to the hydraulic pushing 
system that consists of medical syringes connected to each end of a high pressure flexible 
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P.V.C. tubing of 70 A shore Hardness with polyester braided reinforcements that is filled 
with brake fluid as a hydraulic medium.  The linear motor pushes the end of one syringe 
that then transfers force through the brake fluid to the other syringe.  The end syringe is 
attached in a way that the incoming force is transferred to the ventricle it is trying to 
activate.  The end of the hydraulic system attached to the linear motor was mounted with 
a 30 mL syringe which was 3 times larger than the 10 mL syringe mounted on the 
pushing end.  This helped compensate for the losses obtained along the 11 meter stretch 
of hydraulic tubing needed for M.R.I. experimentation.  The end of the syringe that 
pushes onto the ventricle is mounted with an interchangeable pusher tip that can be 
changed in size and shape to help calibrate the pressure readings obtained by the pressure 
sensors.  Although the activation system does not compress the ventricle uniformly from 
all its sides, this compromise was needed to ensure M.R.I. compatibility within the time 
frame that was presented.  Atrial activation was performed briefly during early 
experimentation where additional pushers were added and aimed at the atrium during its 
respective systolic cycle.  This iteration was not pursued further due to limited 
functionality of the linear motor.  Pressure results obtained from the presented 
experiments therefore only account for the E-wave of the cardiovascular cycle.  The 
missing A-wave is commonly found in patients with atrial fibrillation.  Atrial fibrillation 
is a disease where the atrial upper chambers of the heart beat irregularly and is found in 





3.1.8. Aortic Regurgitation 
 
Although the simulator is capable of representing the complete heart, focus was driven 
towards the left ventricle specifically to observe simulated progression of aortic 
regurgitation, amongst the numerous pathologies that could have been represented using 
this system.  In order to recreate different severities of aortic regurgitation, the aorta 
sinuses were fitted with hemostasis valves and 1 mm diameter transparent fishing wire 
was introduced.  The heart valves were aligned with the aortic sinuses at 120o separation 
allowing control of the leaflets.  The guide wires limited the leaflets ability to close and 
markings along the wire helped test five to nine severities of aortic regurgitation with 
assured repeatability.  As severities of aortic regurgitation would increase, the closing of 
the leaflets were increasingly restricted allowing backflow into the ventricle.  A 
photograph of each aortic regurgitation severity was taken with a Rebel Sony camera 
(Sony Corporation; Minato, Tokyo, Japan) and the R.O.A. (Regurgitant Orifice Area) 
was computed using the photographs and AutoCAD (Autodesk; San Rafael, CA, U.S.A.) 
software.  After every acquisition, the model had to be removed from the M.R.I. scanner 
to set the next severity which was designed to be performed in the least amount of time 
possible.  Although the setup was repeatable to a respectable accuracy, there is still room 




Figure 3.6: Aortic regurgitation setup 
 
3.1.9. Mitral Valve Orientation 
 
In vitro studies about mitral valve orientation effects show important variations when 
compared to normal flow patterns.  Varying prosthetic heart valves, valve geometries, 
flow rate and heart rate all contributed to the recorded differences.  One study proved that 
there are different valve orientations that optimized ventricular flows for each prosthetic 
valve tested [64].  Having access to the mitral valve position in the simulator, acquisitions 
were made at two different orientations by rotating the mitral heart valve.  The objective 
was to determine the effect on flow patterns within the left ventricle during diastole when 
interactions between progressive severities of aortic regurgitation are combined with a 
different mitral valve orientation.  Trying to achieve the same results in vivo would prove 
to be very difficult, if not impossible and typical data retrieved from similar research is 
usually in 2D.  Having the ability to study these controlled effects in three dimensions has 
until now been unobtainable.   
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3.2.1. Magnetic Resonance Imaging  
 
In order to explain the basic principles and functionality of an M.R.I. scanner in as much 
of a concise way as possible, many facts were omitted and the following represents but an 
overview of the underlying science.  Important factors that make M.R.I. acquisitions 
possible are the synchronization with the patient’s ECG signal and the quickness of the 
acquisition which is restricted to the time a patient can potentially hold their breath.  The 
main component is the use of magnets which are represented in the following figure.  The 
field generated by the main magnet core represented by 𝐵! is aligned parallel with the 
length of the patient and is considered the z-axis of the reference coordinate system [65]. 
 
Figure 3.7: Adaptation of the x, y and z gradient coils, integral Rf (Radio frequency) 
transmitter body coils and the main magnet coils which are used to make M.R.I. 
acquisitions possible.  The reference coordinate system used is also demonstrated.  
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Modified from image found in an article of the “Journal of Cardiovascular 
Magnetic Resonance” [65]. 
The magnetic fields are generated by the main magnet coils, three gradient coils for the x, 
y and z directions and an integral Rf transmitter coil which each produce a different type 
of static or pulsatile magnetic field.  The strength of the 𝐵! magnetic field is 
approximately 60000 times stronger than the earth’s magnetic field when operating at 3T 
[65]. 
 
Figure 3.8: Adaptation of the magnetic field surrounding an M.R.I. scanner.  
Modified from image found on the “Radiology Key” website [66] 
 
The three gradient coils produce magnetic fields that can be turned on and off very 
quickly and are aligned in the same z-direction as the 𝐵! field.  Their strength varies 
along the x, y and z directions and the units used for these fields are milli-teslas per meter 
(mT/m).  The radio frequency magnetic fields produced by the Rf transmitter coils are 








generated in an oscillating fashion or a pulse.  The frequency is controlled and measured 
in units of megahertz and the pulsatile field is represented as 𝐵" in the following figure.  
The radio frequency applied is found using the Larmor equation from which the resonant 
frequency or Larmor frequency can be calculated [65].   
𝜔! = 𝛾 ∗ 𝐵! 
 
𝛾 is the gyromagnetic ratio which is usually 42.6 MHz/Tesla and when using a 3T 
magnetic field 𝐵!, the resonant Larmor frequency is approximately 127.8 MHz.  This 
resonant frequency is a pulsatile force and the combination of static and pulsating 
magnetic fields allows signals to be spatially localised and encoded in order to make an 
M.R.I. image.  An addition specifically for cardiovascular M.R.I. imaging is the 
application of an Rf receiver coil which helps maximise the signal received from the 
heart [65].   
 
3.2.2. Molecular Nuclei Magnetisation 
 
Essentially, the MR signal is captured from water or fat within the patient’s tissue and the 
process begins at an atomic level.  Nuclei with an odd number of protons are known as 
MR-active nuclei and have the capability to line up easily with magnetic fields.  
Important elements that have MR-active nuclei include Hydrogen, Carbon, Nitrogen, 
Oxygen, Fluorine, Phosphorus and Sodium [67].  Nuclei of these elements produce a 
small magnetic field for each proton and the net magnetic moment has a tendency to 
align with or against the direction of the 𝐵! field where an equilibrium state is found.  
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Upon application of the Rf pulse, the net magnetisation of molecules is pulled away from 
its equilibrium state and rotates around the z-axis at the same frequency as the resonant 
frequency which is known as precession.  The stronger the rf pulse is, the further away 
from equilibrium the molecules alignment will get and the angle of precession will reach 
a determined value known as the flip angle.  Net magnetisation is represented as 𝑀! and 
when it is aligned with the z-axis is known as its equilibrium position.  The angular 
rotation produced during an Rf pulse can be divided into two directional components.  
The angle made with the z-axis which is known as the longitudinal component and is 
represented as 𝑀#.  The other directional component within the x-y plane is known as the 
transverse component and is represented as	𝑀$%.  
 
Figure 3.9: Adaptation of the net magnetisation 𝑴𝒐  equilibrium which is aligned 
with the z-axis.  During the Rf pulse, the angle between 𝑴𝒐 and the z-axis is 
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𝑴𝒙𝒚  component which lies in the x-y plane.  Modified from image found in an 
article of the “Journal of Cardiovascular Magnetic Resonance” [65] 
This tranverse component of the rotation creates its own small magnetic field which can 
be captured by the Rf receiver coils as an MR signal.  In the absence of the Rf pulse, the 
spin of the molecule rapidly returns to its equilibrium state at a rate known as relaxation 
time [65].  The longitudinal component of the angle will relax back towards the z-axis at 
a rate denoted as the T1 time constant and the tranverse component will decay its rotation 
and signal intensity at a rate denoted as the T2 time constant.  T1 relaxation time 
corresponds to the loss of energy as it returns to equilibrium which is dependent on the 
size of each molecule.  Fat molecules are of a size where their rotation or tumbling rate is 
close to the Larmor frequency which increases the potential for energy exchange and 
therefore makes fat tissues have fast relaxation rates.  Water having a smaller molecular 
size has a quicker tumbling rate than the Larmor frequency and therefore exchanges 




Figure 3.10: Adaptation of T1 relaxation after 90° Rf pulse of the 𝑴𝒛 component.  
T1 time constant is evaluated at 63% of total relaxation time.  Modified from image 
found in an article of the “Journal of Cardiovascular Magnetic Resonance” [65] 
Close proximity to neighbouring proton spins causes T2 relaxation referred to as spin-
spin relaxation.  This phenomenon can be very random and is therefore irreversible.  
Spin-spin relaxation along with inconsistencies in the Bo magnetic field are accounted for 
in T2* relaxation, determined from the actual rate of decay which is known as the F.I.D. 
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Figure 3.11: Adaptation of the tranverse component relaxation after 90° Rf pulse.  
T2* relaxation is the term used for loss of phase coherence and T2* time constant 
represents 37% of initial decaying value after Rf pulse.  Modified from image found 
in an article of the “Journal of Cardiovascular Magnetic Resonance” [65] 
An Rf pulse that causes the net magnetisation to move 90° away from the z-axis is known 
as a saturation pulse which is used to initiate spin echo-based pulse sequences.  Low flip 
angles below 90° as used in the present experiments can be flipped at a quicker rate 
which is used to make gradient echo pulse sequences.  This method is required for faster 
imaging applications.  Following the 90° saturation pulse the z-magnetisation for all 
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following 180° inversion pulse inverts the z-magnetisation for all tissues which then 
recover from their negative or positive values as it flips back and forth with continuous 
180°	inversions.  The imaging pulse sequence that is afterward applied creates a contrast 
which demonstrates shorter T1 relaxation rates like fat tissues that are captured as the 
highest signal intensities and can therefore be differentiated from other tissue [65].   
 
Figure 3.12: Contrast obtained in M.R.I. results of the simulator’s left ventricle 
 
The net magnetisation involves the magnetic moments of all the protons to rotate in a 
coherent fashion and pointing in the same direction during Rf pulses.  The instantaneous 
angle of the direction is known as the phase angle.  When the spins have the same phase, 
they are said to be in-phase and demonstrate coherence.  As previously mentioned, there 
are two things that can cause a loss in coherence of the spins and therefore loss of signal.  
Firstly, the interactions that can occur between protons magnetic fields known as spin-









field	𝐵!.  F.I.D. can be detected and used to create MR imaging but a more common 
practise is to measure the MR signal in the form of an echo for which the two main types 
are gradient or spin echoes [65].  Spin echoes are created by the use of 180° inversions 
from the Rf pulse.  To remove field non-uniformities, the spin de-phasing is completely 
reversed by the end of the echo time.  Spin echo signals are stronger and are less affected 
by the presence of metal components but acquisition times are much longer therefore 
gradient echoes are more commonly used.  Gradient echoes require additional control 
over magnetic field gradients.  The first positive magnetic field causes proton spin to de-
phase whereas the following negative magnetic field gradient reverses the de-phasing 
resulting in the recovery of the F.I.D. signal [65]. 
 
3.2.3. M.R.I. Acquisition Steps 
 
The first step for M.R.I. acquisitions is setting up the slice selection gradient, denoted 
as	𝐺*, which causes the strength of the magnetic field to depend on location along the z-
axis where the Larmor frequency will resonate with patient tissues at a desired plane or 
slice in the field.  The gradient field is activated at the same time as Rf excitation pulse 
which corresponds to the Larmor frequency at a chosen point along the z-axis.  The range 
of frequencies established by the Rf pulse is known as the transmit bandwidth and 




Figure 3.13: Adaptation of step 1 in M.R.I. acquisition which is applying a slice 
selection gradient at the same time as the Rf excitation pulse.  The position along the 
gradient determines resonance between the Larmor frequency and the matching Rf 
pulse denoted as 𝒇𝒐.  Modified from image found in an article of the “Journal of 
Cardiovascular Magnetic Resonance” [65] 
The second step requires the application of a phase encoding gradient, represented as	𝐺+.  
The rotation of protons will vary along the gradient which helps determine the desired 
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signals within the selected slice.  Signal strengths from protons will either decrease or 
increase relative to their position along the gradient as their locations move away from 
the resonating frequency slice [65].  
Finally, the third step requires the application of a frequency encoding gradient, 
represented as	𝐺,.  It is applied in directions that make right angles with the 𝐵! field and 
also causes protons to rotate at frequencies determined by their location along the 
gradient field.   
In summary, three separate magnetic fields are produced in different steps in order to 
obtain an MR signal in 3-dimensions along a plane that is transaxial to the 𝐵! field.  This 
ability to acquire data from any desired slice within the patient is a main reason for 




Figure 3.14: Adaptation of step 2 and 3 of M.R.I. acquisition.  Step 2 involves a 
phase-encoding gradient 𝑮𝒑 that causes phase shifts.  Step 3 is the application of a 
frequency encoding gradient 𝑮𝑭 that determines the Larmor frequency according to 
the desired position.  Modified from image found in an article of the “Journal of 
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Figure 3.15: Adaptation of the pulse sequence diagram that shows the timing of the 
Rf and gradient pulses.  This process ensures the echo signal will be at its strongest 
during acquisition.  Modified from image found in an article of the “Journal of 
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3.2.4. Repetition Time 
 
To construct an image from the acquisition data, a mathematical tool commonly known 
as Fourier transform is used.  This method breaks down the MR signals into its different 
frequency components which can be used to map the location of molecules relative to 
their signal strength [65].  Since Fourier transform requires the signal to change over 
time, multiple signal echoes are repeated with different phase-encoding gradients that 
increase in equal increments known as TR (repetition time).  Repetition time determines 
the speed of image acquisitions and which affects contrast quality of the image.  The 
amount of phase encoding steps used, denoted as	𝑁+, will determine spatial resolution 
and is often limited by acquisition time [65]. 
𝐼𝑚𝑎𝑔𝑒	𝑎𝑐𝑞𝑢𝑖𝑠𝑖𝑡𝑖𝑜𝑛	𝑡𝑖𝑚𝑒 = 𝑇𝑅 ∗ 𝑁+ 
 
Spin echo pulse sequences make use of a flip angle that is fixed at 90°.  Gradient echo 
pulse sequences have the benefit of controlling the T1 and T2 relaxation times on the 
signal with not only repetition and echo times but also with the flip angle used.  Cardiac 
imaging pulse sequences are synchronized with the patient’s heart rate which therefore 
determines repetition time [65].  M.R.I. has its benefits over other cardiovascular data 
collecting methods but has its own limitations that have room for improvement.  Since 
cardiovascular flow happens at such a rapid rate, M.R.I. readings cannot be acquisitioned 
in real time.  The acquisitions captured for this dissertation represented the average of 30 
complete cardiovascular cycles.  An M.R.I. image must be taken in only a few tens of 
milliseconds to limit motion during acquisition which limits the number of encoding 
54 
 
steps and repetition time that affects spatial resolution.  In order to achieve adequate 
image quality, multiple MR signals are acquired over many heart beats which are 
synchronized to the same instance of the R wave of the patients E.C.G. signal [65]. 
 
Figure 3.16: Adaptation of phase encoding steps and repetition time.  The pulse 
sequence is repeated with incremental changes in the phase encoding gradient which 
allows the use of Fourier transform.  Modified from image found in an article of the 




























3.2.5. Flow Velocity Mapping 
 
Flow velocity mapping is the term used when assessing blood flow patterns which is 
obtained using gradient echo pulse sequences.  In order to acquire images rapidly, a 
single shot technique is used known as fast spoiled gradient echo pulse sequences which 
is the best method to observe regurgitation jets.  Since blood flow is too rapid to rely on a 
second pulse to re-phase proton spins, two gradient fields of opposite signs are applied 
along the same direction known as the bipolar gradient pulse pair [68].  The differences 
between blood phases and the phases of stationary tissue help determine the velocity of 
the moving blood which appears as flow voids.  Reducing echo time below 3.6 ms is a 












3.3.1. M.R.I. Parameters for the MaxTron System  
 
 
Figure 3.17: The system within the M.R.I. scanner 
 
M.R.I. data offers many forms of measurement from which the focus of this dissertation 
was drawn towards velocity fields and particle trace mapping.  A few examples of 
hemodynamic quantifications made possible by M.R.I. acquisitions are peak velocity, net 
flow, regurgitant fraction, wall shear stress, pressure difference maps, viscous energy and 
flow displacement [69].  All experimentation involving M.R.I. was made possible by the 
contributions of Dr. Julio Garcia and the Foothills Medical Center in Calgary.  Much care 
was taken towards preserving the integrity of all equipment being used.  Reservoirs for 
the MaxTron system were kept at a distance of about 2 m from the scanner within the 
M.R.I. room.  This was not ideal for safety reasons but helped keep pressure levels of the 
system calibrated.  The M.R.I. scanner used was a Prisma 3T system (Siemens: Munich, 
Germany) with spatial resolution of 2.5 x 2.5 x 2.5 mm3 and temporal resolution of 30-40 
Simulator
Prisma M.R.I.
   scanner
Prisma M.R.I.




ms.  Acquisition times were between 3 and 16 min depending on amount of severities 
being tested.  The method for acquisition uses 3-dimensional phase contrasting (P.C.-
M.R.I.) with respect to time and delivers 3- directional velocity encoding and is termed 
4D flow M.R.I. [70].  The range for VENC (velocity encoding) was typically -150 to 
150(𝑐𝑚 𝑠⁄ ).  Eight phase encoding steps were used with a repetition time of 5.06 ms and 
echo time of 2.36 ms.  A Gadolinium based contrast agent named Gadavist (Bayer: 
Leverkusen, Germany) was added into the water (1	𝑐𝑐 𝑙𝑖𝑡𝑟𝑒C ) during circulation which 
helped with the visualization of the flow.  A low flip angle of 7° was used for fast 
acquisition gradient echo pulse sequencing.  Data pre-processing is a step that involves 
corrections in the form of segmenting the cardiovascular geometry which helped alleviate 
acquisition problems that could affect flow quantification and visualisation.  Main 
sources of errors that can occur within the acquired data are the presence of eddy 
currents, gradient field effects and phase wraps that can produce velocity aliasing.  
Aliasing happens when velocities exceed the pre-determined velocity range limits of the 
acquisition [71]. 
Both standard deviation and noise filters were applied to the M.R.I. data once obtained.  
Matlab (Mathworks; Natick, MA, U.S.A.) versions of the data and files intended for a 
program named Ensight (Siemens; Munich, Germany) were then created.  The files 
uploaded to the Ensight software program made visualization of the flow possible along 








The compatibility of the system when introduced to an M.R.I. environment will be 
discussed first.  Many preparations needed to be done in order to have back-up 
components in the case of failure.  M.R.I. usage for experimentation in this case was 
restricted to hours that the scanner was not being used for clinical purposes, which were 
limited.  First attempts were done using the linear motor to activate both sides of the heart 
which was limited to 50 bpm.  When used for one side only, the system could attain 70 
bpm for the length of acquisition time needed which was between 3 and 16 min.  The 
system was validated by pressures recorded using a fibre optic pressure sensor (FOP-
M260-10 sensor with FPI-HR model, FISO Technologies Inc.; Quebec, Canada) with an 
accuracy of ±3 mmHg.  Flow rate was measured on site using more unconventional 
methods due to no metal components allowed in proximity and were on average around 
1.5 L per min.  This flow rate is considered low but was sufficient to prove the concept of 
this system.  The pressure waveforms presented below were obtained in the aorta, left 
ventricle, right ventricle and pulmonary artery within the L.C.F.D. but not on site during 




Figure 4.1:  Pressure waveforms for both the aorta and left ventricle which were 
obtained simultaneously at 50 bpm 
























Figure 4.2: Pressure readings for both the pulmonary artery and right ventricle 
which were taken simultaneously at 50 bpm 
The above results for the left and right side of the system were taken simultaneously at 50 
bpm.  One can notice that amplitudes reach their targeted values and waveforms are 
smooth.  They have a slightly reversed effect with regards to drops compared to the 
targeted right side pressure waveforms but represent a great step in the right direction.  
The exit tubes of the pulmonary artery were replaced with smaller diameter rubber tubing 
and valves that could regulate the capillary resistance in a repeatable and accurate way. 























4.1.2. M.R.I. Compatibility 
 
One main consideration was signal reception throughout M.R.I. experimentation.  All the 
components of the system proved to be M.R.I. compatible, but certain measures were 
taken to improve the signal obtained during acquisitions.  Water bottles were placed in 
and around the system to capture Rf energy that would usually be absorbed within human 
patients.  Rf receiver coils used to collect signals are basic resistance-capacitance tuned 
antennas that have a saturation limit.  Without the addition of water bottles Rf energy is 
reflected and captured in the coils as a measured signal.  This creates noise in the 
acquired data and could potentially harm the coils.  The following figure demonstrates 
the differences between a high and low signal to noise ratio along with replacement valve 
considerations.  The gap seen in the mitral position in the setup on the left side of the 
heart contained M.R.I. compatible metal whereas the setup on the right housed a Lifelike 
bi-leaflet mitral valve and did not create the same lack of signal in that area.  When inside 
the M.R.I. scanner, the system is strapped to the table using a phase-array body receiver 
coil that mounts over the system and applies downward pressure.  This was further cause 
for loss of signal during acquisitions due to interference caused by the close proximity of 
the coil.  This phenomenon can also be noticed in the right image above the aorta in the 
following figure.  It is also imperative that the heart components and support structures 
move as little as possible during ventricular activation which can cause a tracing effect 




Figure 4.3: Differences in signal reception during acquisitions.  Left side of the 
figure houses two bio-prosthetic valves containing metal components whereas the 
right side of the figure has a bi-leaflet Lifelike valve in the mitral position and 




Proof of concept was achieved and repeated many times to test many severities of aortic 
regurgitation.  From the Ensight software program, 3D visualization of the results is 
made possible.  Planes that are created anywhere along the setup can be used to quantify 
the flow velocities, demonstrate the trajectories taken by particles within the flow and 
color code the velocities with respect to magnitudes.  Another feature easily applied to 
the data is a particle trace image that shows the total trajectory of all the particles being 
observed in the flow.  This allows quick visualisation of turbulence and vortex formations 












involved in the complete cardiac cycle.  The following figure demonstrates 3-dimensional 
results from a front point of view.  The left figure demonstrates the diastolic phase and 
the middle figure depicts the systolic phase.  The figure on the right is a particle trace 
image of the path taken of selected particles during one cardiac cycle. 
 
Figure 4.4: Three-dimensional pathline results from M.R.I. acquisitions.  Left figure 
represents the diastole phase, middle figure represents the systole phase and the 
right figure demonstrates a particle tracing image throughout the entire cardiac 
cycle 
One important observation about the above results is the lack of circulation in the bottom 
half of the ventricle.  This was a result of the contact area available with the pusher 
activation.  This phenomenon is however a consequence of other pathologies that merit 
further studies as well.  Some examples could be interventricular and intraventricular 
dyssynchrony.  Interventricular dyssynchrony is a disease where the left ventricle 
contraction is not synchronized with the right ventricle.  Intraventricular dyssynchrony is 
Diastole Systole Particle trace
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a disease where the contraction of segments of the left ventricle is delayed.  The cardiac 
output remains the same between patients with or without this disease however patients 
with intraventricular dyssynchrony have increased end-diastolic volumes due to the 
shortened filling time [72].  Another example is a disease called giant left atrium disease 
which affects the compression of the left ventricle.  The oversized left atrium compresses 
the posterobasal wall of the left ventricle which bends it against the septal wall that 
separates the right and left ventricles [73].  These diseases could increase the potential for 
stagnation zones in the left ventricle during the cardiac cycle and can be simulated with 
the system. 
 
4.1.4. 2-Dimensional Results 
 
Although 3-dimensional data provides great visualization of flow characteristics, 
quantification for the time being is better achieved using 2-dimensional slices of the 3-
dimensional data.  The post processing for 3-dimensional data requires additional efforts 
that were not permitted during the extent of this project therefore observations will be 
made using 2-dimensional analysis of both pathlines and velocity fields.  Selections were 
made throughout the numerous data sets that highlight the changes in flow when 
severities of aortic regurgitation were induced in a progressive order.  Despite an 
immense learning curve, M.R.I. data was retrieved in 3-dimensions from which flow 
disturbances caused by aortic regurgitation can be visualized.  The 2-dimensional view of 
the velocity fields that will follow are for the moment easier to present and comprehend 




Figure 4.5:  M.R.I. acquisition results of a healthy patient simulated case 
 
The above figure demonstrates one plane within the heart of the system as depicted by 
the pictogram in the lower left hand corners.  At the top of each image, the heart valve 
used for that location is also represented by a pictogram.  The two images on the left are 
still shots of both the pathlines and the velocity vectors during diastole of a healthy heart.  
For the sake of clarity while presenting these results the amount of vectors representing 
the velocity field was reduced to 40% density and the pathlines are represented by arrow 
Pathlines Velocity vectors Pathlines Velocity vectors
Diastole Systole
*Mitral Valve: Mechanical, Aortic Valve: Biocor bio-tissue, 3 leaflet regurgitation
  R.O.A.(Regurgitant Orifice Area): 0.00 cm  2
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heads that match their magnitudes respectively.  The two images on the right side of the 
figure represent the pathlines and velocity vectors of the systolic phase of the same 
cardiac cycle acquisition.  The above figure was the first results obtained with the system 
and is referred to as setup 1.  A mechanical heart valve was used for the mitral location 
and a bio-tissue heart valve was used for the aortic location.  These preliminary readings 
were scattered with noise which were associated to the learning curve as can be noticed 
in the second image of the above figure.  Observations of the mitral inflow which is 
directed toward the tip of the apex at the bottom of the left ventricle can be easily 
visualized along with fluid interactions with the ventricle walls represented by the two 
images on the left.  Very clear pathlines of fluid leaving the ventricle towards the aortic 
valve can also be visualised in both left images.  The uniqueness of the MaxTron system 
is that from the same M.R.I. results, any plane in the system during the cardiac cycle can 
be analysed which till now has not been a possibility on any in vitro system of this 
caliber.  To keep this dissertation concise only a few examples of the limitless 




Figure 4.6:  Mitral and aortic view of M.R.I. results of a normal patient simulated 
case 
 
The two images on the left side of the above figure are the diastolic pathlines and velocity 
vectors of an orthogonal plane extending from the mitral valve location to the apex or tip 
of the left ventricle as depicted in the pictogram.  The images on the right side of the 
above figure represent the systolic pathlines and velocity vectors from another orthogonal 
plane extending from the center of the aorta towards the posterior wall of the left 
Mitral view pathlines Mitral view vectors Aortic view pathlines Aortic view vectors
Diastole Systole
*Mitral Valve: Mechanical, Aortic Valve: Biocor Bio-tissue, 3 leaflet regurgitation
  R.O.A.(Regurgitant Orifice Area): 0.00 cm2
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ventricle and are also depicted in the pictogram.  These views of the cardiac cycle are 
rarely observed and offer a clearer image of flow characteristics from a different 
perspective. 
 
4.1.5. Aortic Regurgitation Simulation 
 
A few iterations were brought to the system which allowed the simulation of aortic 
regurgitation.  Although many lessons had already been learnt, there were still many 
stepping stones of apprenticeship conquered during the preceding iterations.  Insight to 
the hemodynamics involved with aortic regurgitation is essential towards developing 
better diagnostic methods, medical devices and patient specific parameters.  Throughout 
the testing of progressive severities of aortic regurgitation many complications limited 
the consistency of the results therefore selections of a few acquisitions will be presented 
which fulfill the objective of discovering the feasibility of the system.  The following 




Figure 4.7: M.R.I. acquisitions of a mild aortic regurgitation simulation 
 
A quick observation in the above figure can be made about the beginning of flow 
disturbance during each phase.  During diastole, the regurgitant jet can be noticed 
colliding with mitral inflow causing slight disruptions.  The same regurgitant jet persists 
during systole.  The cause for this was the Lifelike heart valve chosen for the mitral 
location during this iteration.  The Lifelike valve offered physiological mitral inflow but 
due to the fact that it was not properly tethered made it not close efficiently during the 
*Mitral Valve: Lifelike bio-tissue, Aortic Valve: Biocor bio-tissue, 3 leaflet regurgitation 
  R.O.A.(Regurgitant Orifice Area): 0.125 cm 2
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systolic phase.  The effects of aortic regurgitation can however be observed with the 
addition of multiple views from the same cardiac cycle. 
 
Figure 4.8:  Mitral and aortic view of M.R.I. acquisition results of mild aortic 
regurgitation simulation 
 
This iteration was conducted with aortic regurgitation affecting 3 leaflets.  The R.O.A. 
(Regurgitant Orifice Area) of this iteration was smaller than a more severe iteration 
Mitral Mitral Aortic Aortic
Systole
Mitral view pathlines Mitral view vectors Aortic view pathlines Aortic view vectors
Diastole
*Mitral Valve: Lifelike bio-tissue, Aortic Valve: Biocor bio-tissue, 3 leaflet regurgitation 
  R.O.A.(Regurgitant Orifice Area): 0.125 cm 2
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affecting only one leaflet which will be presented below.  The direction of the regurgitant 
jet along with the size of the leaking orifice both plays a role in the increased disturbance 
of the flow. 
 
Figure 4.9:  M.R.I. acquisition results of severe aortic regurgitation simulation 
 
An increase in flow disturbance proportional to the increase in R.O.A. can be noticed in 
the above figure.  Although the cardiac cycle is difficult to distinguish with this iteration 
Mitral Mitral Mitral MitralAortic AorticAorticAortic
Pathlines Velocity vectors Pathlines Velocity vectors
Diastole Systole
*Mitral Valve: Lifelike bio-tissue, Aortic Valve: Biocor bio-tissue, 1 leaflet regurgitation 
  R.O.A.(Regurgitant Orifice Area): 0.496 cm 2
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there is still an opportunity to gain insight.  One important observation is how regurgitant 
mitral inflow seems to diminish in the presence of a stronger aortic regurgitant jet.   
 
4.1.6. Mitral Valve Orientation 
 
An observation was made throughout experiment iterations where the mitral valve had 
been placed at a different angle as opposed to its anatomical placement which led to the 
mitral inflow jet being aimed towards the septal wall instead of the posterior wall of the 
left ventricle.  This phenomenon when mixed with different severities of aortic 
regurgitation had some interesting outcomes that are worth noticing.  The incoming aortic 
regurgitant jet collides with the misaligned mitral inflow jet in such a way that the flow 




Figure 4.10: Mitral orientation change M.R.I. acquisition results for severe aortic 
regurgitation simulation 
Due to minimized acquisition time the cycle was not completely registered but the effect 
of a reversed vortex can be noticed in the diastolic results of both pathlines and velocity 
vectors.  The angle at which both incoming jets are placed optimizes an immediate 
mixture of the jets into one with minimal disturbance leading to a near laminar flow.  The 
flow had a tendency to remain the same despite the progressions of increasing severities 




*Mitral Valve: Biocor bio-tissue, Aortic Valve: Biocor bio-tissue, 1 leaflet regurgitation 
  R.O.A.(Regurgitation Orifice Area): 0.496 cm 2
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hemodynamics with regards to flow displacement but these findings merit further 
investigation.  An example that comes to mind is if a patient was in need of both an aortic 
and mitral heart valve replacement surgery, one option depending on the patient’s age 
and risk factors could be to only replace the mitral heart valve and have it orientated in 
such a way to minimize the need to repair the aortic heart valve.  This could prove 



















A major contribution from this experiment towards improving cardiovascular research 
was the durability of the heart components.  The 3D printed silicone hearts produced by 
the University of Zurich have a life span of approximately 30 min [56].  The heart 
components produced in the L.C.F.D. laboratories have proven that they can be used for a 
much longer duration and the same heart cavities have been used throughout this 
research.  The main focus of the project however was M.R.I. compatibility which shall 
now be further discussed.  The production of heart components was proven possible 
through the use of Ninjaflex 3D printing filament.  The implementation of an 
interchangeable 3D printed support structure was proven effective to house any type of 
structural support with the ultimate goal of patient specific representation.  This gives the 
MaxTron heart simulator system unlimited potential to expand research capability 
towards a multitude of options.  This includes extending the amount of pathologies 
covered in cardiovascular related fields along with other organs that might interact with 
these pathologies.  With the advancements in tissue engineering, enhanced heart 
components will represent the ultimate addition to these types of simulators.  Dual 
material 3D printed heart components will soon have the potential to accurately 
distinguish mechanical properties of natural heart components.  The M.R.I. compatibility 
of the simulator and all its components was therefore achieved and validated with the 
pressure waveforms.  Aortic regurgitation was simulated through progressive states of 
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severities and even though the results are rudimentary, they represent a positive step 
towards bettering cardiovascular fluid dynamic research.  Through the course of 
experimentation it was also noticed that mitral inflow orientation can have a positive 
effect on flow disturbance caused by increasing severities of aortic regurgitation. 
One of the biggest limitations throughout these experiments was the low flow rate.  
Future iterations of these heart simulators are presently being worked on at the L.C.F.D.  
The system will definitely benefit from the addition of a soft robotic or origami activation 
system to increase the flow rate and minimize components needed for activation of the 
circulatory system.  Attempts are being made to incorporate soft robotic tubing in a 
helical fashion within the ventricle walls which when activated will create a more 
realistic replica of how the heart actually contracts its myocardial muscle fibres to 




Figure 5.1: Adaptation of the theoretical placement of soft robotics inside heart 
component walls enabling realistic compression of the heart.  Modified from image 
found on the “Soft Robotics Toolkit” website [74]  
A brief mention that there are many other different tasks that the simulator can 
accomplish.  One field of research that is increasing in importance is the effects of zero 
gravity on the cardiovascular circulatory system.  Space flight involves many unanswered 
questions when cardiovascular functionality is concerned.  Current studies performed in a 
zero gravity environment show significant cardiovascular changes in endothelial cells 
that line up the vasculatory network of arteries and heart chambers [75] which could 
potentially be simulated with the MaxTron system.  Other future advancements in 
cardiovascular research involve many companies like I.B.M., Apple and Google which 
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are investing in developing and adapting artificial intelligence that could possibly assist 
in diagnostics.  A.I. has the advantage of being able to assess large amounts of data [76]. 
5.1.2. Limitations  
 
The most important improvement to the acquisitions would be to solve the trigger issues 
that start the acquisition at a desired instance.  The problem of trigger signal reception 
was evasive because the signal was being sent properly with the correct impedance 
however the M.R.I. scanner was not detecting the signal for some unknown reason.  
Water was used for these experiments but future use of a water-glycerol solution would 
prove more physiologically correct.  Flow rate was low which was due to the linear motor 
limitations.  Other limitations included pusher contact area with respect to the ventricle 
compressions which could benefit from further iterations with the goal of distributing 
compression more evenly and starting from the apex of the ventricle working upward.  
Adapting the system so the torso casing could be filled completely with liquid would help 
the signal reception for M.R.I. readings and would add the availability to the system to 
house Lifelike heart components made from tissue engineered materials that need to be 
constantly submerged in liquid.  A quicker connection and disconnection method could 
further user-friendliness of the system and would help reduce acquisition times.   
Research in this field is very gratifying due to the severity and abundance of 
cardiovascular diseases within the global population.  Medical device testing, medical 
education and cardiovascular fluid dynamics will continue to benefit from the 
advancements in medical simulators which increase competency of device designers and 
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Appendix 4 System Maintenance 
 
The system was designed to have as little maintenance as possible.  A few important 
strategies have been implemented to ensure longevity of the system.  The linear motor 
can benefit from regular greasing at intervals of approximately 30000 cycles.  The 
circulatory system including reservoirs, tubing and heart components can occasionally be 
rinsed thoroughly with vinegar and water to eliminate the chance for fungicidal build up.  
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Disadvantages of the system are minimal and include regular small procedures to ensure 
proper functionality.  The medical syringes used in the hydraulic activation system 
always need to be prepared back into motion slowly if they have been without use for 
more than one day and this inconsistency could easily be improved through further 
iterations of design changes.  The biological heart valves need to be removed from the 
system and placed in water when the system is drained between uses in order to maintain 
the flexibility of the leaflets.  To increase the lifespan of all 3D printed components, it is 
best to minimize the amount of loading they carry when the system is not being used 
which involves emptying all fluid from the system at the end of operations.  Heat can be a 
serious threat to the system because 3D printed components tend to shrink when 
subjected to elevated temperatures.  The repetitive action performed on the ventricles can 
cause them to wear thin which is cause for regular observation.  The torso should be 
handled with care when being mobilized because solid 3D printed components along with 
the fiberglass mannequin torso are brittle. 
 
Appendix 5 Experimentation Iterations 
 
Primary results of pressure waveforms were far from accurate and the reason was 
because the set up at the time of these readings had no capillary resistance in the form of 
valves along the exit or return flow pathways.  The Pulmonary Artery would branch off 
into two separate paths that were followed by soft rubber tubing with 1/2 inch inner 
diameter and 1/8 inch thickness.  This was changed for the next iteration because it was 
believed to be the issue of why the pressure waves were different then the target 
waveforms.  Another factor that played an important role towards achieving better 
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pressure waveforms was the fact that the opacity of the 3D printed heart components 
made it very hard to rid the system of all air bubbles which compromise the pressure 
reading accuracy.  The results for the left ventricle pressure readings would show a dip in 
the waveform at the peak of the wave which is directly related to the air bubbles that 
were trapped in the system.  With the previous silicone heart components it would be 
easier to locate and rid the system of all the air bubbles thanks to the transparency of the 
components.  After a few attempts, an adequate procedure of placing the system to 
relieve all the trapped air was found and pressure readings slowly became more 
acceptable.  Pressure waveforms obtained from the right ventricle showed that changing 
the exit tubing of the pulmonary artery for more flexible tubes was beneficial for 
decreasing the amplitude of the waveform which was close to 70 mmHg and should have 
been near 25.  A solution for more flexible tubing was found in the form of long birthday 
balloons which offered the ultimate elasticity that was readily available to the general 
public.  The system was updated with an extra set of hydraulic pushers that would act 
upon the atriums.  When the right ventricle would begin its systolic cycle, which is when 
the ventricle is filled with fluid, the linear motor would be in retraction pulling the pusher 
off the ventricle allowing it to fill itself up with gravity potential from the elevated 
reservoir.  The second hydraulic system was attached to the returning end of the linear 
motor meaning that it would push and activate the right atrium while the right ventricle 
was filling up.  Since the right atrium empties into the right ventricle, the pushers helped 
the filling process.  When the pusher of the ventricle would activate and apply pressure 
on the ventricle, the return stroke of the atrium pusher was relieved allowing the atrium to 
refill itself from the reservoir directly.  The use of the secondary hydraulic system was 
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proven effective and added to the realism of the simulation but was not developed further 
due to the force budget that the linear motor was capable of.   
Different methods were attempted where either squeezing was performed on tube 
sections at different locations or the tubes were placed at different elevations to calibrate 
the pressure readings.  The good thing that came from this trial was that the waveforms 
were looking more like the target waveforms of a healthy heart.  However, the 
disadvantage was that results were difficult to reproduce since the means in obtaining 
them were very specific and not measurable through that approach.  Another important 
factor that helped the stabilization of the pressure readings was the extra support added to 
the heart support structure.  The vibrations caused by the loose components really 
hindered the progress of the research and once dealt with relieved the results from non-
physiological effects. 
The left side, although rudimentary, represents an entirely different approach than 
previously attempted.  The 3D printed aorta was replaced by a custom silicone 
component which adds the advantage of transparency for air bubble elimination and 
recreates the medical training simulation of transcatheter procedures more accurately than 
rubber tubing.   
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